InvestorsHub Logo
Followers 84
Posts 1123
Boards Moderated 0
Alias Born 09/10/2017

Re: coldasice post# 11395

Wednesday, 09/19/2018 4:02:01 PM

Wednesday, September 19, 2018 4:02:01 PM

Post# of 12137
Okay Cold, I give you credit for sticking to your statement once again (as laughable as it is). I do respect your opinion, so now that I have your attention; I recall last year when you were posting several times about McKesson working with Cryooport and posing questions to the board. I admit I was sandbagging you on my lack of appreciation for the unannounced McKesson “partnership” with Cryoport to see what you knew. You only said that I needed to do more DD, but I’m wondering now if you knew about the MediLedger Project and thought the same thing that Cryoport is involved? I thought Cryoport was positioning itself to be at the very center of the Big Pharma cold-chain outsourcing wave. Cryoport has now signed agreements with 2 of the 3 major distributors in the U.S. that are working on the MediLedger Project, with the other major distributor, Cardinal potentially joining the Project. I think Wold Courier integrating the Cryoportal into their global network is a big deal, but like you, I’d like to know how to quantify the revenue potential. As you may know, this Big Pharma outsourcing was my primary reason for investing here last due to the huge near-term revenue potential. I thought the gene therapy revenue was icing on the cake but would take 2-3 years to build, but it now appears longer. I’m beginning to second guess my original thesis and wondering if I’m the only one to be digging down this rabbit hole? You seemed to be the only one here looking at Cryoport’s software angle.

The MediLedger Project was started in 2017 by Chronicled to bring together leading Pharmaceutical Manufacturers and Distributors to explore blockchain technology to meet track and trace regulations, and to provide a step function improvement in the overall operation of the supply chain. The project is receiving support from supply chain consulting group The LinkLab, has been building its software using Quorum, an enterprise version of the Ethereum protocol backed by JP Morgan.


Big Pharma builds blockchain prototype to stop counterfeits
PUBLISHED Sept. 21, 2017
https://www.supplychaindive.com/news/big-pharma-blockchain-MediLedger-DSCSA-FDA/505563/

Phase 2: Big Pharma expands its blockchain experiment
PUBLISHED June 14, 2018
https://www.supplychaindive.com/news/big-pharma-blockchain-experiment-returns/525689/

AmerisourceBergen, Merck to Expand Blockchain Test Project for Tracking Drugs
by Anatol Antonovici, 08 June
https://cryptovest.com/news/amerisourcebergen-merck-to-expand-blockchain-test-project-for-tracking-drugs/


Recent Drug Scandals in China Spotlight Potential Global Supply Chain Issues
Published: Aug 07, 2018 By Mark Terry
https://www.biospace.com/article/recent-drug-scandals-in-china-spotlight-potential-global-supply-chain-issues/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYRX News